Mitsuyoshi Morii

Title: Mitsuyoshi Morii: Innovator in Tissue Plasminogen Activator Purification

Introduction

Mitsuyoshi Morii is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of biochemistry, particularly in the purification of tissue plasminogen activator (tPA). With a total of 5 patents to his name, Morii's work has had a substantial impact on medical science.

Latest Patents

One of Morii's latest patents is a method for purifying a crude tissue plasminogen activator preparation. This innovative technique effectively separates tPA from undesired proteins using a cation-exchanger in a two-step procedure. In the first step, undesired proteins with a pI equivalent to or lower than that of tPA are eluted, while in the second step, those with a pI equivalent to or higher than tPA are removed. Another notable patent involves a purification procedure of tPA from crude preparations. This method utilizes an affinity reagent containing an immobilized Kunitz inhibitor, which selectively collects tPA while not affecting urokinase.

Career Highlights

Mitsuyoshi Morii is associated with Mitsui Toatsu Chemicals, Incorporated, where he has been instrumental in advancing research and development in biochemistry. His innovative approaches to purification processes have garnered attention in the scientific community.

Collaborations

Morii has collaborated with notable colleagues, including Masaharu Ohoka and Nobuhiro Kawashima. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Mitsuyoshi Morii's contributions to the field of tissue plasminogen activator purification highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving purification techniques, which can have significant implications for therapeutic applications.